IFN-DC loaded with an immunogenic tumor cell lysate can elicit lymphoma-specific CTL in an experimental model of mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL) [63]. This evidence concerns the gene IFNA1 and mantle cell lymphoma.